This is the text extract for Optimal Use of Medicines, browse documents here.
One Heart Many Lives
Click here to view video
Some questions….
• Why do we spend money on medicines that aren’t prescribed,
dispensed or used properly?
We miss out on health outcomes and other health interventions
• Why is there more focus on new medicines instead of
best use of what we have?
• Why are there big differences in medicines access in NZ?
It's not ok - we need to do more about it
Why is PHARMAC in this space?
Help make the best use of the pharmaceutical budget
– – – –
encourage appropriate medicines provision & use promote demand, e.g. statins reduce demand, e.g. wise use of antibiotics avoid inefficiency and reduce disparity
Medicines our core business
– –
skills, competency and experience national focus
Responsible use of medicines is a statutory function
The way that we work
Work closely across the health and social sector Key relationships with health professionals as well as consumers including PHARMAC’s Consumer Advisory Committee Focus on inequalities through the PHARMAC Māori Responsiveness Strategy
Identify issue and seek primary healthcare assistance
Medicines selection
Medicines dispensed
Medicines taken (right person, dose, time and duration)
Pharmaceutical companies Reassessment
Access & Optimal Use Campaigns
• • • • • • •
Asthma Antibiotics Atypical antipsychotics BPAC nz Diabetes Gout Gut Reaction
One Heart Many Lives Polypharmacy SPARC He Rongoa Pai – He Oranga Whanau • Te Whaioranga
• • • •
Hospitalisations for asthma for year ending May 2007
18.00 16.00 Hospitalisations per '000 14.00 12.00 10.00 8.00 6.00 4.00 2.00 0.00 0-4 Years 5-9 Years 10-14 Years 15-19 Years Age group Maori Pacific Island European
Asthma SABA/ICS Ratios: all NZ
Asthma SABA/ICS Ratios: Maori
Asthma SABA/ICS Ratios: Pacific
Asthma SABA/ICS Ratios: NZ European
Access & Optimal Use Tools
• • • • • • • •
Stakeholder relationships including consumers Social marketing Community development Maori Responsiveness Strategy Tangata Pasifika relationships Workforce development Best Practice Advocacy Centre Research, evidence and guidelines
How can we improve access to and optimal use of medicines?
Marama Parore Manager, Access and Optimal Use Pou Arahi, Te Whaioranga Maori Health Team
Metadata
Title
Abstract
One Heart Many Lives Some questions…. • Why do we spend money on medicines that aren’t prescribed, dispensed or used properly? We miss out on health outcomes and other health interventions • Why is there more focus on new medicines…
Page 1
Note
This text has been extracted from the source PDF document.
Also available as plain text.
Please contact webmaster to discuss alternative format options.